Search Results - "Kerkman, D J"

Refine Results
  1. 1

    Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI by EWERS, M, BUERGER, K, WALLIN, A, DEBERNARDIS, J. F, KERKMAN, D. J, HEINDL, B, BLENNOW, K, HAMPEL, H, TEIPEL, S. J, SCHELTENS, P, SCHRÖDER, J, ZINKOWSKI, R. P, BOUWMAN, F. H, SCHÖNKNECHT, P, SCHOONENBOOM, N. S. M, ANDREASEN, N

    Published in Neurology (11-12-2007)
    “…The measurement of hyperphosphorylated tau (p-tau) in CSF has been proposed as a biomarker candidate for the prediction of Alzheimer disease (AD) in patients…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Characterization of antihypertensive activity of ABBOTT-81988, a nonpeptide angiotensin II antagonist in the renal hypertensive rat by Lee, J Y, Buckner, S A, Brune, M E, Warner, R B, Winn, M, De, B, Zydowsky, T M, Opgenorth, T J, Kerkman, D J, Debernardis, J F

    “…2-(N-Propyl-N[(2'-[1H-tetrazol-5-yl]biphenyl-4yl)methyl]amin o) pyridine-3-carboxylic acid (ABBOTT-81988), a novel nonpeptide angiotensin II (AII) antagonist,…”
    Get more information
    Journal Article
  6. 6

    Antihypertensive activity of ABBOTT-81282, a nonpeptide angiotensin II antagonist, in the renal hypertensive rat by Lee, J Y, Brune, M E, Warner, R B, Buckner, S B, Winn, M, De, B, Zydowsky, T M, Opgenorth, T J, Kerkman, D J, DeBernardis, J F

    Published in Pharmacology (01-09-1993)
    “…ABBOTT-81282, 4-(N-butyl-N-[(2-'-[1H-tetrazol-5yl]biphenyl-4-yl)methyl]ami no) pyrimidine-5-carboxylic acid is a novel nonpeptide angiotensin II (AII)…”
    Get more information
    Journal Article
  7. 7

    Cardiovascular effects of orally administered ABBOTT-81988, an angiotensin II antagonist, in conscious spontaneously hypertensive rats by Lee, J Y, Warner, R B, Brune, M E, Adler, A L, Winn, M, De, B, Zydowsky, T M, Opgenorth, T J, Kerkman, D J, DeBernardis, J F

    Published in American journal of hypertension (01-11-1994)
    “…ABBOTT-81988 (A-81988), 2-(N-propyl-N[(2'-[1H-tetrazol-5-yl]biphenyl- 4yl)methyl] amino) pyridine-3-carboxylic acid, a nonpeptide angiotensin II (AII)…”
    Get more information
    Journal Article
  8. 8

    A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor by Kerkman, D J, Ackerman, M, Artman, L D, MacKenzie, R G, Johnson, M C, Bednarz, L, Montana, W, Asin, K E, Stampfli, H, Kebabian, J W

    Published in European journal of pharmacology (03-08-1989)
    “…A-69024 HBr, 1-(2-bromo-4,5-dimethoxybenzyl)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4- tetrahydroisoquinoline hydrobromide, is a selective antagonist of the…”
    Get more information
    Journal Article
  9. 9

    A new nasal decongestant, A-57219: a comparison with oxymetazoline by DeBernardis, J F, Winn, M, Kerkman, D J, Kyncl, J J, Buckner, S, Horrom, B

    Published in Journal of pharmacy and pharmacology (01-09-1987)
    “…2-(4-Amino-3,5-dichlorobenzyl)imidazoline hydrochloride (A-57219), has alpha 1-agonist/alpha 2-antagonist activity and was more effective and long-acting than…”
    Get more information
    Journal Article
  10. 10

    Adrenergic and dopaminergic properties of dopamine sulfoconjugates by Kyncl, J J, Buckner, S A, Brondyk, H, Kerkman, D J, DeBernardis, J F, Bush, E N, Kuchel, O

    Published in Journal of cardiovascular pharmacology (01-11-1985)
    “…The 3- and 4-sulfate esters of dopamine (DA-3-SO4 and DA-4-SO4, respectively), the two main metabolites of DA, were evaluated for potential intrinsic or…”
    Get more information
    Journal Article
  11. 11

    Pharmacological characterization of Abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptors by Hancock, A A, Buckner, S A, Lee, J Y, Brune, M, Morse, P A, Oheim, K, Warner, R B, Winn, M, Zydowsky, T M, De, B

    Published in Life sciences (1973) (1993)
    “…Abbott-81282 (A-81282) has been identified among a series of related compounds as being a highly potent and selective antagonist of angiotensin receptors. At…”
    Get more information
    Journal Article
  12. 12

    Effects of the putative antidepressant, ABT 200, on the clearance of exogenous norepinephrine in rat cerebellum by Cass, W A, Friedemann, M N, deBernardis, J F, Kerkman, D J, Gerhardt, G A

    Published in Synapse (New York, N.Y.) (01-09-1995)
    “…ABT 200 [(RR,SS)-3-phenyl-1-[1',2',3',4'-tetrahydro-5',6'-methylenedioxy- 1'-naphthalenyl-methyl]-pyrrolidine methanesulfonate] is a potent alpha…”
    Get more information
    Journal Article
  13. 13

    Conformationally defined adrenergic agents. 4. 1-(Aminomethyl)phthalans: synthesis and pharmacological consequences of the phthalan ring oxygen atom by DeBernardis, John F, Arendsen, David L, Kyncl, John J, Kerkman, Daniel J

    Published in Journal of medicinal chemistry (01-01-1987)
    “…The synthesis of a series of 1-(aminomethyl)phthalans 1b is reported. The radioligand binding to alpha 1- and alpha 2-receptors and the in vitro pharmacology…”
    Get full text
    Journal Article
  14. 14

    Conformationally defined adrenergic agents. 1. Design and synthesis of novel alpha 2 selective adrenergic agents: electrostatic repulsion based conformational prototypes by DeBernardis, J F, Kerkman, D J, Winn, M, Bush, E N, Arendsen, D L, McClellan, W J, Kyncl, J J, Basha, F Z

    Published in Journal of medicinal chemistry (01-10-1985)
    “…A previous report of the adrenergic selectivity of 2- and 6-fluoronorepinephrine prompted us to formulate a hypothesis that accounted for this selectivity on…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Conformationally defined adrenergic agents. 2. Catechol imidazoline derivatives: biological effects at alpha 1 and alpha 2 adrenergic receptors by DeBernardis, J F, Kyncl, J J, Basha, F Z, Arendsen, D L, Martin, Y C, Winn, M, Kerkman, D J

    Published in Journal of medicinal chemistry (01-04-1986)
    “…The synthesis and pharmacology of 2-(5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthyl)imidazoline (A-54741, 4), a very potent alpha-adrenergic agonist, are…”
    Get full text
    Journal Article
  17. 17

    [3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors by Hancock, A A, Surber, B W, Rotert, G, Thomas, S, Tasker, A S, Sorensen, B K, Vodenlich, A D, Opgenorth, T J, Kerkman, D J, DeBernardis, J F

    Published in European journal of pharmacology (15-03-1994)
    “…Abbott-81988 (A-81988), 2-(N-n-Propyl-N-[(2'-[1H-tetrazol-5-yl]biphenyl-4- yl)methyl]amino)pyridine-3-carboxylic acid is a potent, competitive, non-peptidic…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Conformationally defined adrenergic agents. 3. Modifications to the carbocyclic ring of 5,6-dihydroxy-1-(2-imidazolinyl)tetralin: improved separation of alpha 1 and alpha 2 adrenergic activities by DeBernardis, J F, Winn, M, Arendsen, D L, Kerkman, D J, Kyncl, J J

    Published in Journal of medicinal chemistry (01-08-1986)
    “…A series of modifications to positions 1, 2, and 4 of the tetralin ring of 5,6-dihydroxy-1-(2-imidazolinyl)tetralin (1, A-54741) succeeded in improving the…”
    Get full text
    Journal Article